vab-1 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of Vab1 Antibody

Vab1 is a monoclonal antibody (mAb) derived from B cell-derived vesicles integrating receptor-effector modules (B-VIREMs). It specifically targets stomatin, a ubiquitously expressed intracellular scaffold protein involved in membrane organization and vesicular trafficking . Unlike conventional antibodies requiring opsonization (coating by immune proteins), Vab1 enables phagocytes to recognize antigens directly, bridging innate and adaptive immune functions .

Mechanism of Action

Vab1 operates through an opsonization-independent pathway:

  1. Self-loading: Co-expression with CD32A allows Vab1 to arm phagocytes during vesicular transport to the cell surface .

  2. Antigen binding: Recognizes stomatin on cell debris, latex beads, or erythrocyte membrane ghosts .

  3. Phagocytosis: Engages Fc receptors to trigger engulfment, enhancing debris clearance by 2.5-fold compared to unarmed cells .

Key Functional AssaysResultsSource
Immunoprecipitation + mass spectrometry72% overlap with commercial anti-stomatin
Phagocytosis of stomatin-coated beads2.5x increase in HL-60 cell activity
Erythrocyte ghost uptakeSuccessful; intact erythrocytes not targeted

Antigen Specificity

  • Stomatin specificity confirmed via 24 immunoprecipitation experiments across human cell lines, PBMCs, and erythrocytes .

  • Binds recombinant stomatin-glutathione S-transferase fusion protein, depleting it from solution .

Therapeutic Potential

  • Tissue maintenance: Facilitates clearance of cellular debris in inflammatory or degenerative conditions .

  • Autoimmunity risks: Stomatin is strictly intracellular; Vab1’s targeting of exposed stomatin in debris avoids healthy cell damage .

Comparative Advantages Over Conventional Antibodies

FeatureVab1Traditional mAbs
Opsonization requirementNot requiredRequired
Antigen accessibilityTargets intracellular proteinsLimited to surface antigens
Stability in serumResists IgG displacementCompetes with serum IgG

Future Directions

  • Therapeutic applications: Explored for autoimmune diseases and chronic inflammation .

  • Engineering: Fusion with cytotoxic agents for targeted drug delivery .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (made-to-order)
Synonyms
vab-1 antibody; M03A1.1 antibody; Ephrin receptor 1 antibody; EC 2.7.10.1 antibody; Tyrosine-protein kinase Eph receptor antibody; Variable abnormal protein 1 antibody
Target Names
vab-1
Uniprot No.

Target Background

Function

VAB-1 is a receptor for ephrin family members and major sperm proteins (MSPs). It acts as a sperm-sensing checkpoint, inhibiting oocyte meiotic maturation and ovulation in the absence of sperm. Specifically, it negatively regulates oocyte maturation and MAPK activation when MSPs are unavailable. VAB-1 is also crucial for MSP-mediated increases in basal sheath cell contraction rates in somatic cells. Furthermore, it phosphorylates and likely promotes the degradation of the phosphatase DAF-18/PTEN, thereby positively regulating the insulin-like DAF-2 signaling cascade. VAB-1 plays a role in interactions between neuronal substrate cells and migrating epithelial sheets during head epidermis morphogenesis, cell movements post-gastrulation and ventral epidermal closure, and potentially spermatheca morphogenesis. It is also involved in axon guidance of SDQL neurons during neurogenesis.

Gene References Into Functions

Functional Studies of VAB-1:

  1. Increased locomotion speed correlates with higher nicotine concentrations in all mutant strains except vab-1 mutants. PMID: 26574927
  2. EFN-1 (VAB-2) expression analysis indicates that VAB-1 functions within amphid neurons, interacting with EFN-1 on surrounding cells. PMID: 23979582
  3. VAB-1 inhibits axonal outgrowth by suppressing filopodia formation at the growth cone. This is achieved through Arp2/3 activation via a VAB-1/NCK-1/WSP-1 complex and UNC-34/Ena inhibition. PMID: 22383893
  4. VAB-1's role in germline apoptosis affects specific cell death pathways, potentially alongside extracellular signal-regulated kinase (MAPK) signaling. PMID: 22240896
  5. During body wall closure, VAB-1 kinase activity is essential for bridge cell extension over scaffold cells to the ventral midline. PMID: 22197242
  6. VAB-1 has been identified as a major sperm protein receptor. PMID: 12533508
  7. VAB-1 and SAX-3/Robo cooperate in gastrulation cleft closure and ventral epidermal enclosure. PMID: 16033794
  8. Upon MSP binding, VAB-1 transitions from a negative to a redundant positive regulator of oocyte maturation. This switch is mediated by NMR-1 through UNC-43 CaMKII activation at the oocyte cortex. PMID: 16267094
  9. VAB-1 is crucial for targeting or limiting axons and neuronal cells to specific locations, potentially by transducing repellent or stop signals. PMID: 16386725
  10. Mutations in ina-1 (α-integrin), vab-1, and vab-2 (ephrin) all result in embryonic muscle cell migration defects. PMID: 18452914
  11. Regulated endocytic trafficking of the VAB-1 MSP/Eph receptor influences oocyte meiotic maturation. PMID: 18472420
  12. Hypoxia affects axon pathfinding, at least partly, through HIF-1-dependent regulation of VAB-1. PMID: 18587389
Database Links

KEGG: cel:CELE_M03A1.1

STRING: 6239.M03A1.1b

UniGene: Cel.5002

Protein Families
Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily
Subcellular Location
Cell membrane; Single-pass type I membrane protein.
Tissue Specificity
During ventral enclosure of the epidermis, expression is seen in clusters of presumptive head neuronal cells and several cells in the tail region. Early larvae show expression in the nerve ring and ventral nerve cord. Strong expression is also seen in the

Q&A

Basic Research Questions

What is the biological role of VAB-1 in C. elegans axon guidance?

VAB-1, an Eph receptor tyrosine kinase (RTK), regulates axon guidance by interacting with the NCK-1 adaptor protein. Genetic studies show that vab-1 mutations lead to premature axon termination in PLM neurons, partially suppressed by nck-1(ok694) (a null allele). This indicates NCK-1 acts downstream of VAB-1 but requires additional effectors for full functionality .

Methodological Insight:

  • Use genetic suppression assays (e.g., crossing vab-1 mutants with nck-1 mutants) to validate functional interactions.

  • Live-imaging techniques in C. elegans larvae can track growth cone dynamics during axon pathfinding .

How does the NCK-1 SH2 domain mediate interaction with VAB-1?

The SH2 domain of NCK-1 binds phosphorylated tyrosine residues on activated VAB-1. GST pull-down assays confirmed this interaction is kinase-dependent and specific:

  • Key tyrosine residue: Y673 in VAB-1’s juxtamembrane domain .

  • Specificity: NCK-1 SH2 showed no binding to kinase-inactive VAB-1 (G912E mutant) or other SH2 domains (e.g., MIG-10, SEM-5) .

Experimental Design:

  • Perform site-directed mutagenesis on VAB-1 tyrosines.

  • Use phospho-specific antibodies in Western blots to confirm activation states .

Advanced Research Questions

How to resolve contradictions in genetic vs. biochemical data for VAB-1 signaling?

Partial suppression of vab-1 phenotypes by nck-1 mutants suggests additional effectors. Strategies include:

  • Proteomic screening for VAB-1-binding partners beyond NCK-1.

  • Epistasis analysis to identify parallel pathways (e.g., UNC-34/Enabled regulation) .

Table 1: Conflicting observations and resolution approaches

ObservationMethodResolution
nck-1(ok694) partially rescues PLM defectsGenetic suppressionTest double mutants with unc-34
NCK-1 binds VAB-1, but other SH2 domains do notGST pull-down assaysScreen for novel adaptors

What methods optimize VAB-1 antibody validation for structural studies?

  • Antigen-specific validation: Use recombinant VAB-1 extracellular domain in ELISA.

  • Functional assays: Compare antibody binding to wild-type vs. kinase-dead (G912E) VAB-1 in immunoprecipitation .

  • Cross-reactivity checks: Test against related Eph receptors (e.g., human EphA4) to confirm specificity .

How to assess VAB-1’s role in dynamic cellular processes like phagocytosis?

While VAB-1 is primarily studied in axon guidance, its Eph RTK properties may intersect with immune functions:

  • Live-cell imaging: Track VAB-1 localization during phagocytosis in C. elegans coelomocytes.

  • RNAi knockdown: Combine with opsonization assays (e.g., using fluorescently tagged bacteria) .

What statistical pipelines are recommended for antibody array data involving VAB-1?

For high-throughput antibody interaction data:

  • Preprocessing: Normalize signal intensities using quantile normalization.

  • Differential analysis: Apply linear models (e.g., limma package in R) to identify significant interactors.

  • Functional annotation: Use Gene Ontology enrichment for pathways like “axon guidance” or “RTK signaling” .

Data Interpretation Challenges

How to address low reproducibility in VAB-1 antibody-based assays?

  • Standardize protocols: Use defined C. elegans developmental stages (e.g., L1 larvae) to minimize variability.

  • Multiplex validation: Combine Western blot, immunostaining, and genetic rescue experiments .

  • Negative controls: Include vab-1 null mutants in all assays .

Key Takeaways:

  • VAB-1’s interaction with NCK-1 is critical but not exclusive for axon guidance.

  • Methodological rigor (e.g., kinase activity assays, SH2 domain specificity tests) is essential for mechanistic studies.

  • Advanced techniques like smFRET or cryo-EM could be adapted to study VAB-1 conformational changes in future work.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.